Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
2E82KzYj7Mn5Fq8n
